Piperazine

Piperazine

SCHEMBL4432094

C1CNCCN1.CCc1ccnc(Cl)c1

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ESR1

The experimentally established mechanism targets of Piperazine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.52
LOX P28300 1/20 0.52
LOXL3 P58215 1/20 0.52
LOXL2 Q9Y4K0 1/20 0.52
NOS3 P29474 1/20 0.47
NOS1 P29475 1/20 0.47
NOS2 P35228 1/20 0.47
TLR9 Q9NR96 1/20 0.41
TLR8 Q9NR97 1/20 0.41
TLR7 Q9NYK1 1/20 0.41
GRM5 P41594 1/20 0.39
NISCH Q9Y2I1 2/20 0.37
GHSR Q92847 1/20 0.37
CXCR4 P61073 1/20 0.37
EPHX1 P07099 1/20 0.35
PARP10 Q53GL7 1/20 0.35
PARP11 Q9NR21 1/20 0.35
SYK P43405 1/20 0.34
AURKB Q96GD4 1/20 0.34
INCENP Q9NQS7 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL805501 0.89
Methylene Chloride SCHEMBL28291344 0.85 RECQL (0.59) RECQLLOXLOXL3LOXL2NOS3
SCHEMBL12538821 0.75 CXCR4 (0.61) RECQLLOXLOXL3LOXL2CXCR4
SCHEMBL4438687 0.73 RECQL (0.59) RECQLLOXLOXL3LOXL2NOS3
SCHEMBL14640057 0.71 CXCR4 (0.76) CXCR4HRH3
SCHEMBL8511962 0.71 SLC6A4 (0.54) RECQLLOXLOXL3LOXL2TLR9
SCHEMBL11919149 0.71 ADRB1 (0.55) NOS3NOS1NOS2KCNH2HRH4
Hydrochloric Acid SCHEMBL31061226 0.70 ADRB1 (0.54) NOS3NOS1NOS2KCNH2HRH4
SCHEMBL1503624 0.70
SCHEMBL22878184 0.69 RECQL (0.53) RECQLLOXLOXL3LOXL2NOS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097413-A1 2-[(2-SUBSTITUTED)-IND0LIZIN-3-YL]-2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G Limited (GB) 2009-09-09 EP disclosed
WO-2008062182-A1 2- [ (2-SUBSTITUTED) -IND0LIZIN-3-YL] -2-OXO-ACETAMIDE DERIVATIVES AS ANTIFUNGAL AGENTS F2G LTD (GB) 2008-05-29 WO disclosed